Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination

@inproceedings{Walker2017QualityOL,
  title={Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination},
  author={Daniel J. Walker and Melissa P. Delbello and John L. Landry and Deborah N. D’Souza and Holland C. Detke},
  booktitle={Child and adolescent psychiatry and mental health},
  year={2017}
}
BACKGROUND We examined the efficacy of olanzapine/fluoxetine combination (OFC) in improving health-related quality of life (QoL) in the treatment of bipolar depression in children and adolescents. METHODS Patients aged 10-17 years with bipolar I disorder, depressed episode, baseline children's depression rating scale-revised (CDRS-R) total score ≥40, Young Mania Rating Scale (YMRS) total score ≤15, and YMRS-item 1 ≤ 2 were randomized to OFC (6/25-12/50 mg/day olanzapine/fluoxetine; n = 170… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS